Literature DB >> 12923913

TNM staging for malignancies of the digestive tract: 2003 changes and beyond.

Frederick L Greene1.   

Abstract

In preparation for the 6th edition of the UICC and AJCC publications on TNM staging, all data regarding sites of the digestive system (gastrointestinal and hepatobiliary) were reviewed by expert site teams. Although the information for several sites (esophagus, small bowel, and anal canal) required no change from the 5th editions, significant changes were recommended for the pancreas, liver, extrahepatic biliary system, colon, and rectum. Minor but important changes were made regarding gastric and peri-ampullary malignancies. The changes were made based on new prognostic information and analysis of available data sets. The importance of large national registries, such as the National Cancer Data Base (NCDB; American College of Surgeons Commission on Cancer), is stressed. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12923913     DOI: 10.1002/ssu.10018

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  22 in total

1.  Differences in overall survival when colorectal cancer patients are stratified into new TNM staging strategy.

Authors:  Ho-Suk Oh; Hyoung-Jung Chung; Hearn-Kook Kim; Jong-Soo Choi
Journal:  Cancer Res Treat       Date:  2007-06-30       Impact factor: 4.679

2.  Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma.

Authors:  Jian-Wei Zhang; Yun-Mian Chu; Zhong-Min Lan; Xiao-Long Tang; Ying-Tai Chen; Cheng-Feng Wang; Xu Che
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

3.  Increased expression of tumor necrosis factor-α is associated with advanced colorectal cancer stages.

Authors:  Omar A Al Obeed; Khayal A Alkhayal; Abdulmalik Al Sheikh; Ahmad M Zubaidi; Mansoor-Ali Vaali-Mohammed; Robin Boushey; James H Mckerrow; Maha-Hamadien Abdulla
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 4.  Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.

Authors:  Francesca Panzeri; Stefano Crippa; Paola Castelli; Francesca Aleotti; Alessandro Pucci; Stefano Partelli; Giuseppe Zamboni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

5.  Tumor necrosis factor-α is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-α agents in cancer treatment.

Authors:  M Grimm; M Lazariotou; S Kircher; A Höfelmayr; C T Germer; B H A von Rahden; A M Waaga-Gasser; M Gasser
Journal:  Cell Oncol (Dordr)       Date:  2011-08       Impact factor: 6.730

6.  Surgical treatment for isolated inguinal lymph node metastasis in lower rectal adenocarcinoma patients improves outcome.

Authors:  Tomohiro Adachi; Takao Hinoi; Hiroyuki Egi; Hideki Ohdan
Journal:  Int J Colorectal Dis       Date:  2013-07-09       Impact factor: 2.571

7.  Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer?

Authors:  Ibrahim Sakcak; Barış Doğu Yıldız; Fatih Mehmet Avşar; Saadet Akturan; Kemal Kilic; Erdal Cosgun; Enver O Hamamci
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

8.  Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer.

Authors:  Byung Woog Kang; Jong Gwang Kim; Yee Soo Chae; Yoo Jin Lee; Soo Jung Lee; Joon Ho Moon; Sang Kyun Sohn; Min Kyu Jung; Seong Woo Jeon; Yun-Jin Jang; Jongduk Seo; Yong Hyun Lee; Ohkyung Kwon; Ho Young Chung; Wansik Yu
Journal:  Invest New Drugs       Date:  2011-08-17       Impact factor: 3.850

9.  The effect of adjuvant chemotherapy on stage IV (T4N1-3M0 and T1-3N3M0) gastric cancer.

Authors:  Tae Kyung Ha; Min Sung Jung; Kang Hong Lee; Kyeong Geun Lee; Sung Joon Kwon
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

10.  Gallbladder cancer with duodenal infiltration: is it still resectable?

Authors:  Anil K Agarwal; Sanjoy Mandal; Shivendra Singh; Puja Sakhuja; Sunil Puri
Journal:  J Gastrointest Surg       Date:  2007-09-29       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.